New ointment RSS0393 aims to clear psoriasis and ease itch in major trial
NCT ID NCT07543224
First seen Apr 28, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This phase 3 study tests an ointment called RSS0393 against a placebo in 600 adults with mild-to-moderate plaque psoriasis. The main goal is to see if the ointment improves skin clearing and reduces itching after 8 weeks. Participants must have had psoriasis for at least 6 months and have 2-20% of their body affected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital (PUMCH)
Beijing, Beijing Municipality, 100730, China
Contact
Conditions
Explore the condition pages connected to this study.